Tag: Entheon Biomedical - Page 2 - Psychedelic Alpha

Read more about the article Entheon Biomedical Announces EEG Patent Application & Provides Research Update

Entheon Biomedical Announces EEG Patent Application & Provides Research Update

Post published:December 16, 2021
Post category:Press Release

Read more about the article Psychiatrist and Addiction Researcher, Dr. Henry Kranzler Joins Entheon Advisory Board

Psychiatrist and Addiction Researcher, Dr. Henry Kranzler Joins Entheon Advisory Board

Post published:December 1, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs

Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs

Post published:November 24, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Announces Recruitment Underway in EBIQ-101 Clinical Study

Entheon Biomedical Announces Recruitment Underway in EBIQ-101 Clinical Study

Post published:November 10, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials

Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials

Post published:October 27, 2021
Post category:Press Release

Read more about the article Clinical Director of Imperial College’s Center for Psychedelic Research Joins Entheon Advisory Board

Clinical Director of Imperial College’s Center for Psychedelic Research Joins Entheon Advisory Board

Post published:August 25, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Corp. Acquires Lobo Genetics Inc.

Entheon Biomedical Corp. Acquires Lobo Genetics Inc.

Post published:July 30, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana

Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana

Post published:June 30, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wave

Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wave

Post published:June 22, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc.

Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc.

Post published:June 16, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.